Company / Book Value per Share
Supernus Pharmaceuticals, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$19.047
FY2025
5-year range
$15.432 / $19.047
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
#30 of 209
Health Care
What the data says
Supernus Pharmaceuticals, Inc.'s book value per share of $19.047 is higher than 86% of companies in the Health Care sector (FY2025). Improved from $16.602 to $19.047 over the past 2 years.
Based on SEC 10-K filings.
$19.047 in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $16.602 to $19.047 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 209This company $19.047 Sector average $189.406
▼
-89.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2025, book value per share increased 0.6% year-over-year.
- Ranks #30 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.047 | +0.6% |
| FY2024 | $18.927 | +14.0% |
| FY2023 | $16.602 | -0.2% |
| FY2022 | $16.64 | +7.8% |
| FY2021 | $15.432 | +8.8% |
| FY2020 | $14.179 | +24.6% |
| FY2019 | $11.381 | +204.6% |
| FY2018 | $3.737 | +112.2% |
| FY2017 | $1.761 | +112.1% |
| FY2016 | $0.831 | -59.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026